|
|
Aradigm Corporation - Medical Equipment - Deals and Alliances Profile |
| Published Date : 17 February 2010 |
|
|
|
Pages : 27 |
|
| |
|
|
|
|
|
|
|
Aradigm Corporation - Medical Equipment - Deals and Alliances Profile
Summary
Aradigm Corporation - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
Aradigm Corporation (Aradigm) is a specialty pharmaceutical company engaged in the development and commercialization of drugs delivered by inhalation for treating severe respiratory diseases by pulmonologists. It has developed pulmonary drug delivery system, AERx Essence and AERx Strip Technology for the delivery of drugs to the target. The company's current pipeline comprises of products used for treating cystic fibrosis, inhalation anthrax and bronchiectasis. Additionally, it plans to use its technology for tobacco smoking cessation therapy. Aradigm is headquartered at Hayward in California, the US.
And More inside the report…
Recent Developments
Aug 06, 2009: Aradigm Reports Net Loss Of $4.6 Million In Q2 2009
Jul 23, 2009: Aradigm Gets FDA Clearance For Phase IIb Ciprofloxacin Trial
May 12, 2009: Aradigm Posts Net Loss Of $5.2 Million For Q1 2009
Scope
- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Company Mentioned
The following companies are the major competitors of Aradigm Corporation:
Bayer HealthCare AG
Nektar Therapeutics
Pfizer Inc. |
|
|
|
Table of Contents : |
2
List of Tables 3
List of Figures 3
Aradigm Corporation, Medical Equipment, Deals By Year, 2004 to YTD 2010 4
Aradigm Corporation, Medical Equipment Deals By Type, 2004 to YTD 2010 5
Aradigm Corporation, Medical Equipment, Deals By Region, 2004 to YTD 2010 6
Aradigm Corporation, Medical Equipment, Deals By Market, 2004 to YTD 2010 7
Aradigm Corporation, Medical Equipment, Deals Summary, 2004 to YTD 2010 8
Aradigm Corporation, Medical Equipment, Deal Details 9
Partnerships 9
Aradigm And Lung Rx Enter Into License Agreement 9
Equity Offering 10
Aradigm Completes Private Placement Of $4.46 Million 10
Aradigm Completes Public Offering Of $36 Million 12
Aradigm Completes Private Placement Of $13 Million 13
Divestiture - Assets 14
Aradigm Sells Intraject Technology To Zogenix 14
Key Competitors 15
Key Employees 15
Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Strategy And Business Planning 16
Jul 19, 2007: Aradigm Enters Sublease Agreement With Mendel 16
Financial Announcements 16
Aug 06, 2009: Aradigm Reports Net Loss Of $4.6 Million In Q2 2009 16
May 12, 2009: Aradigm Posts Net Loss Of $5.2 Million For Q1 2009 17
Mar 25, 2009: Aradigm Posts Net Loss Of $22.6 Million In 2008 17
Nov 12, 2008: Aradigm Declares 3Q 2008 Results 18
Aug 08, 2008: Aradigm Reports 2Q 2008 Results 19
May 14, 2008: Aradigm Declares Q1 2008 Results 20
Mar 25, 2008: Aradigm Declares Q4 2007 Results 20
Nov 08, 2007: Aradigm Declares Q3 2007 Results 21
Aug 09, 2007: Aradigm Declares Q2 2007 Results 22
May 10, 2007: Aradigm Declares Q1 2007 Results 23
Mar 29, 2007: Aradigm Declares Q4 2006 Results 23
Nov 10, 2006: Aradigm Declares Q3 2006 Results 23
Aug 10, 2006: Aradigm Declares Q2 2006 Results 24
Corporate Communications 25
Sep 18, 2008: Aradigm Appoints CFO 25
Jan 02, 2008: Aradigm Appoints New Board Member 25
Jul 05, 2007: Aradigm Appoints Interim CFO 25
Jun 05, 2007: Aradigm CFO To Leave 25
Nov 09, 2006: Aradigm To Delist From NASDAQ Capital Market 25
Nov 06, 2006: Aradigm Appoints Board Member 25
Oct 24, 2006: Aradigm Requests Hearing Regarding Listing On NASDAQ 25
Aug 24, 2006: Aradigm Receives Grant For Continued Listing On NASDAQ 26
Aug 10, 2006: Aradigm Appoints President & CEO 26
Jun 29, 2006: Aradigm Receives Grant For Hearing On Nasdaq Delisting Determination 26
Jun 23, 2006: Aradigm Receives Nasdaq Staff Determination Letter 26
Legal and Regulatory 26
Jul 19, 2007: Aradigm Enters Sublease Agreement With Mendel 26
Other Significant Developments 26
Nov 24, 2008: Aradigm CEO To Present At Piper Jaffray Conference 26
Appendix 27
Methodology 27
About Global Markets Direct 27
Contact Us 27
Disclaimer 27
List of Tables
Aradigm Corporation, Medical Equipment, Key Facts, 2008 1
Aradigm And Lung Rx Enter Into License Agreement 9
Aradigm Completes Private Placement Of $4.46 Million 10
Aradigm Completes Public Offering Of $36 Million 12
Aradigm Completes Private Placement Of $13 Million 13
Aradigm Sells Intraject Technology To Zogenix 14
List of Figures
Aradigm Corporation, Medical Equipment, Deals By Year, 2004 to YTD 2010 4
Aradigm Corporation, Medical Equipment, Deals by Type, 2004 to YTD 2010 5
Aradigm Corporation, Medical Equipment, Deals By Region, 2004 to YTD 2010 6
Aradigm Corporation, Medical Equipment, Deals by Market, 2004 to YTD 2010 7 |
|
|
|
Published By : GlobalData |
|
|
Related
Keywords:
Energy,
Insurance, Financial,
Company Profile,
Industry Profile,
Swot Analysis,
Apparel,
Consumer, Trade,
Information technology,
Food,
Healthcare,
Construction,
Retail,
Design,Oil
and Gas,
Solar,
Miscellaneous,
Business,
Pharmaceuticals,
Technology,
Defense,
Medical,
Travel,
Power,
Metal
|
|
|
|
